Topical agents for the treatment of psoriasis, past, present and future.
Tremblay
Jean-François
JF
Division of Dermatology, University of Montreal Hospital Centre, Notre Dame Hospital, Montreal, Quebec, Canada. rbissonn@globetrotter.net
Bissonnette
Robert
R
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000875:Anthralin / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D003033:Coal Tar / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage*; D009539:Nicotinic Acids / Q000008:administration & dosage; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy*; D014807:Vitamin D / Q000008:administration & dosage; D012176:Retinoids
D000305:Adrenal Cortex Hormones; D000875:Anthralin; D000893:Anti-Inflammatory Agents; D003033:Coal Tar; D007641:Keratolytic Agents; D009539:Nicotinic Acids; D014807:Vitamin D; C086827:tazarotene; D012176:Retinoids